Researchers investigating age-related muscle degeneration have reported promising findings showing that photobiomodulation (PBM), a form of low-intensity red light therapy, may help restore function in aging neuromuscular junctions (NMJs) — the critical connections between nerves and muscle fibers.

The study, titled “Ultrastructural Signs of High Functional Activity of Neuromuscular Synapses in Aging Rats After Photobiomodulation,” examined the effects of PBM on skeletal muscle tissue in aged rats and found evidence of structural changes associated with improved neuromuscular activity.

Neuromuscular junctions play an essential role in maintaining muscle strength and mass by transmitting signals from the nervous system to muscle fibers. Degeneration of these junctions is considered a major contributor to sarcopenia and dynapenia, the age-related loss of muscle mass and strength.

In the study, researchers treated the vastus lateralis muscles of 18-month-old male Wistar rats with low-intensity red light at a wavelength of 650 nm over four consecutive days. Untreated muscles on the opposite limbs served as controls.

Microscopic analysis revealed that untreated muscles displayed typical signs of aging, including irregular muscle fiber size, connective tissue buildup, fragmented myofibrils, disorganized sarcomeres, and accumulation of cellular waste products such as lipofuscin.

By contrast, muscles exposed to photobiomodulation showed several changes associated with increased neuromuscular activity. Researchers observed an increase in active zones on presynaptic membranes, elongation of postsynaptic membranes, narrowing of synaptic clefts, and mitochondrial hyperplasia within nerve terminals. These changes suggest that PBM may stimulate compensatory remodeling of aging neuromuscular junctions.

The findings add to growing interest in photobiomodulation as a non-invasive therapeutic strategy for combating age-related muscle decline. PBM, commonly delivered through low-level red laser light therapy, is believed to enhance mitochondrial function, although the precise biological mechanisms remain under investigation.

Despite the encouraging results, experts caution that clinical enthusiasm should be tempered. While photobiomodulation has been widely used in clinical settings for years, large-scale human evidence demonstrating substantial improvements in muscle function remains limited. Questions also persist regarding how effectively red wavelengths penetrate deeper tissues in larger animals and humans.

Researchers say further studies will be needed to determine whether the structural improvements observed in animal models can translate into meaningful functional benefits in aging human populations.